Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of Sweetened Dried Cranberry Consumption on Urinary Proteome and Fecal Microbiome in Healthy Human Subjects. ✅
Go to Publication ✅
Omics : a journal of integrative biology (OMICS ) Vol: 22 Issue 2 Pages: 145-153 Pub: 2018 Feb Epub: 2017 Jun 15 Authors Bekiares N , Krueger CG , Meudt JJ , Shanmuganayagam D , Reed JD , |
|
|
Curated database of commensal, symbiotic and pathogenic microbiota ✅
Generative Bioinformatics (Center of Excellence in Generative Medicine ) Vol: Issue Pages: Pub: 2014 Jun Epub: Authors D'Adamo Peter , |
|
|
A polyphenol-rich cranberry extract reverses insulin resistance and hepatic steatosis independently of body weight loss. ✅
Go to Publication ✅
Molecular metabolism (Mol Metab ) Vol: 6 Issue 12 Pages: 1563-1573 Pub: 2017 Dec Epub: 2017 Oct 18 Authors Anhê FF , Nachbar RT , Varin TV , Vilela V , Dudonné S , Pilon G , Fournier M , Lecours MA , Desjardins Y , Roy D , Levy E , Marette A , |
|
|
Triggering Akkermansia with dietary polyphenols: A new weapon to combat the metabolic syndrome? ✅
Go to Publication ✅
Gut microbes (Gut Microbes ) Vol: 7 Issue 2 Pages: 146-53 Pub: 2016 Epub: Authors Anhê FF , Pilon G , Roy D , Desjardins Y , Levy E , Marette A , |
|
|
Strategies to promote abundance of <i>Akkermansia muciniphila</i>, an emerging probiotics in the gut, evidence from dietary intervention studies. ✅
Go to Publication ✅
Journal of functional foods (J Funct Foods ) Vol: 33 Issue Pages: 194-201 Pub: 2017 Jun Epub: 2017 Mar 29 Authors Zhou K , |
|
|
Anti-obesity effects of a-amylase inhibitor enriched-extract from white common beans (Phaseolus vulgaris L.) associated with the modulation of gut microbiota composition in high-fat diet-induced obese rats. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 11 Issue 2 Pages: 1624-1634 Pub: 2020 Feb 26 Epub: Authors Shi Z , Zhu Y , Teng C , Yao Y , Ren G , Richel A , |
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Explanations/Info/Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations. Please report any to us for correction.
Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.